Amendment to Product License. Dyax agrees that it shall not amend the Product License in any way that materially and adversely affects or reduces the rights and licenses granted to Sublicensee under this Sublicense.
Appears in 5 contracts
Sources: Collaboration Agreement (Elevation Oncology, Inc.), Technology Transfer and License Agreement (Dyax Corp), Collaboration Agreement (Merrimack Pharmaceuticals Inc)